PHARMACYTE BIOTECH, INC. Amortization of Debt Discount (Premium)
PHARMACYTE BIOTECH, INC. (PMCB) reported Amortization of Debt Discount (Premium) of $0 for the 12-month period ending 2015-04-30, per its 10-K/A filed 2016-01-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2016-01-19
- PHARMACYTE BIOTECH, INC. amortization of debt discount (premium) for the quarter ending 2014-04-30 was $0.00.
- PHARMACYTE BIOTECH, INC. amortization of debt discount (premium) for the quarter ending 2014-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. amortization of debt discount (premium) for the quarter ending 2013-10-31 was $0.00.
- PHARMACYTE BIOTECH, INC. amortization of debt discount (premium) for the quarter ending 2013-07-31 was $0.00.
- PHARMACYTE BIOTECH, INC. amortization of debt discount (premium) for fiscal 2015 was $0.00.
- PHARMACYTE BIOTECH, INC. amortization of debt discount (premium) for fiscal 2014 was $0.00.
- PHARMACYTE BIOTECH, INC. amortization of debt discount (premium) for fiscal 2013 was -$5.70K.
- PHARMACYTE BIOTECH, INC. amortization of debt discount (premium) for fiscal 2012 was -$10.80K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2015-04-30 | $0.00 10-K/A · filed 2016-01-19 | |||
| 2014-04-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-19 | $0.00 derived: sum of 2 quarters · filed 2016-01-19 | $0.00 derived: sum of 3 quarters · filed 2016-01-19 | $0.00 10-K/A · filed 2016-01-19 |
| 2014-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | $0.00 derived: sum of 4 quarters · filed 2016-01-19 |
| 2013-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-16 | $0.00 10-Q · filed 2013-12-16 | $0.00 derived: sum of 3 quarters · filed 2016-01-19 | $0.00 derived: sum of 4 quarters · filed 2016-01-19 |
| 2013-07-31 | $0.00 10-Q · filed 2013-09-16 | $0.00 derived: sum of 2 quarters · filed 2016-01-19 | $0.00 derived: sum of 3 quarters · filed 2016-01-19 | $0.00 derived: sum of 4 quarters · filed 2016-01-19 |
| 2013-04-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-19 | $0.00 derived: sum of 2 quarters · filed 2016-01-19 | $0.00 derived: sum of 3 quarters · filed 2016-01-19 | -$5.70K 10-K/A · filed 2016-01-19 |
| 2013-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | -$5.70K 10-Q · filed 2014-03-17 | -$8.40K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-16 | -$5.70K 10-Q · filed 2013-12-16 | -$8.40K derived: sum of 3 quarters · filed 2013-12-16 | -$11.10K derived: sum of 4 quarters · filed 2013-12-16 |
| 2012-07-31 | -$5.70K 10-Q · filed 2013-09-16 | -$8.40K derived: sum of 2 quarters · filed 2013-09-16 | -$11.10K derived: sum of 3 quarters · filed 2013-09-16 | -$13.79K derived: sum of 4 quarters · filed 2013-09-16 |
| 2012-04-30 | -$2.70K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | -$5.40K derived: sum of 2 quarters · filed 2013-07-29 | -$8.10K derived: sum of 3 quarters · filed 2013-07-29 | -$10.80K 10-K · filed 2013-07-29 |
| 2012-01-31 | -$2.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-26 | -$5.40K derived: sum of 2 quarters · filed 2013-03-26 | -$8.10K 10-Q · filed 2013-03-26 | -$10.80K derived: sum of 4 quarters · filed 2013-03-26 |
| 2011-10-31 | -$2.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-26 | -$5.40K 10-Q · filed 2012-12-26 | -$8.10K derived: sum of 3 quarters · filed 2012-12-26 | -$10.80K derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-07-31 | -$2.70K 10-Q · filed 2012-09-19 | -$5.40K derived: sum of 2 quarters · filed 2012-09-19 | -$8.10K derived: sum of 3 quarters · filed 2012-09-19 | -$10.80K derived: sum of 4 quarters · filed 2012-09-19 |
| 2011-04-30 | -$2.70K derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-14 | -$5.40K derived: sum of 2 quarters · filed 2012-08-14 | -$8.10K derived: sum of 3 quarters · filed 2012-08-14 | -$10.80K 10-K · filed 2012-08-14 |
| 2011-01-31 | -$2.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-21 | -$5.40K derived: sum of 2 quarters · filed 2012-03-21 | -$8.10K 10-Q · filed 2012-03-21 | |
| 2010-10-31 | -$2.70K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2011-12-15 | -$5.40K 10-Q · filed 2011-12-15 | ||
| 2010-07-31 | -$2.70K 10-Q/A · filed 2011-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |